Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lewis

Showing results (1121-1130 of 1,275) with videos related to

Pageof 128
Sort By:
American Heart Journal|December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAkshay S Desai, Eldrin F Lewis, Rebecca Li, et al.
The Journal of Clinical Psychiatry|May 25, 2010
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trialTheresa M Winhusen, Eugene C Somoza, Gregory S Brigham, et al.
Circulation. Heart Failure|October 8, 2009
Predictors of heart failure in patients with stable coronary artery disease: a PEACE studyEldrin F Lewis, Scott D Solomon, Kathleen A Jablonski, et al.
The American Journal of Cardiology|January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)Thao Huynh, Brian J Harty, Brian Claggett, et al.
Kidney Medicine|February 3, 2025
Incident Heart Failure in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of the CORAL TrialRajesh Gupta, Michelle M Estrella, Rebecca Scherzer, et al.
Journal of the American Heart Association|December 18, 2023
Opportunities to Increase Science of Diversity and Inclusion in Clinical Trials: Equity and a Lack of a ControlJoseph-Kevin Igwe, Tenzin Yeshi Wangdak Yuthok, Erin Cruz, et al.
Diabetologia|July 21, 2017
IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodentsAleksandar Ivovic, Andrei I Oprescu, Khajag Koulajian, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Journal of the American College of Cardiology|June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarctionDavid Aguilar, Hicham Skali, Lemuel A Moyé, et al.
Circulation|March 25, 2017
Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart AssociationDaniel E Forman, Ross Arena, Rebecca Boxer, et al.
Pageof 128

Showing results (1121-1130 of 1,275) with videos related to

Sort By:
Pageof 128
American Heart Journal|December 6, 2011
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAkshay S Desai, Eldrin F Lewis, Rebecca Li, et al.
The Journal of Clinical Psychiatry|May 25, 2010
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trialTheresa M Winhusen, Eugene C Somoza, Gregory S Brigham, et al.
Circulation. Heart Failure|October 8, 2009
Predictors of heart failure in patients with stable coronary artery disease: a PEACE studyEldrin F Lewis, Scott D Solomon, Kathleen A Jablonski, et al.
The American Journal of Cardiology|January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)Thao Huynh, Brian J Harty, Brian Claggett, et al.
Kidney Medicine|February 3, 2025
Incident Heart Failure in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of the CORAL TrialRajesh Gupta, Michelle M Estrella, Rebecca Scherzer, et al.
Journal of the American Heart Association|December 18, 2023
Opportunities to Increase Science of Diversity and Inclusion in Clinical Trials: Equity and a Lack of a ControlJoseph-Kevin Igwe, Tenzin Yeshi Wangdak Yuthok, Erin Cruz, et al.
Diabetologia|July 21, 2017
IKKβ inhibition prevents fat-induced beta cell dysfunction in vitro and in vivo in rodentsAleksandar Ivovic, Andrei I Oprescu, Khajag Koulajian, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Journal of the American College of Cardiology|June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarctionDavid Aguilar, Hicham Skali, Lemuel A Moyé, et al.
Circulation|March 25, 2017
Prioritizing Functional Capacity as a Principal End Point for Therapies Oriented to Older Adults With Cardiovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart AssociationDaniel E Forman, Ross Arena, Rebecca Boxer, et al.
Pageof 128